Evidence map›Paper›PMID 36897530›Full record

ArticleQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation2023

A national survey of Iranian general population to estimate a value set for the EQ-5D-5L.

Somayeh Afshari, Rajabali Daroudi, Reza Goudarzi, Alireza Mahboub-Ahari, Mehdi Yaseri, Ali Akbari Sari, Hosein Ameri, Sajjad Bahariniya, Alireza Oliaei-Manesh, Khalil Kalavani and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Cost-effectiveness of plasmapheresis and hemoperfusion in COVID-19 survivors: A six-month follow-up analysis after hospital discharge.Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy · 2026
    Article
  5. A cross-country comparison of the psychometric performance of SF-6Dv2 and EQ-5D-5L.The European journal of health economics : HEPAC : health economics in prevention and care · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. EQ-5D-5L Iranian population norms derived from the local value set during the COVID-19 pandemic.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2025
    Article
  12. From Rich to Poor: A Decomposition Analysis of Socioeconomic Inequality in Health-related Quality of Life in Iran.Journal of preventive medicine and public health = Yebang Uihakhoe chi · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Valuation of the EQ-5D-3L in Jordan.The European journal of health economics : HEPAC : health economics in prevention and care · 2025
    Article
  17. Article
  18. EQ-5D-5L value set for Norway: a hybrid model using cTTO and DCE data.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2025
    Article
  19. Valuing the SF-6Dv2 in the capital of Iran using a discrete choice experiment with duration.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Somayeh AfshariDepartment of Health Management, Policy, and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Rajabali DaroudiDepartment of Health Management, Policy, and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Reza GoudarziHealth Services Management Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Alireza Mahboub-AhariIranian Evidence Based Medicine Center, Department of Health Economics, Tabriz University of Medical Sciences, Tabriz, Iran.
Mehdi YaseriDepartment of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Ali Akbari SariDepartment of Health Management, Policy, and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. akbarisari@tums.ac.ir.
Hosein AmeriDepartment of Health Management and Economics, School of Public Health, Health Policy and Management Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. hamery7@yahoo.com.ORCID http://orcid.org/0000-0002-9914-034X
Sajjad BahariniyaDepartment of Health Management and Economics, School of Public Health, Health Policy and Management Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Alireza Oliaei-ManeshNational Institute for Health Research, Tehran University of Medical Sciences, Tehran, Iran.
Khalil KalavaniDepartment of Health Management, Policy, and Economics, School of Management and Medical Information Sciences, Kerman University of Medical Sciences, Kerman, Iran.
Zahra ZareDepartment of Health Care Management, Shiraz University of Medical Sciences, Shiraz, Iran.
Elham HasannezhadDepartment of Health Management, Policy, and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Mohammadamin MirzaeiMaster of Actuarial Science, ECO College of Insurance, Allameh Tabatabae'i University, Tehran, Iran.
Zahra AmiriDepartment of Pharmacoeconomics and Pharmaceutical Management, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.

Funding

Tehran University of Medical Sciences and Health Services 25073
6 · The paper itself

Abstract

objectivesThe main aim of this study is to estimate a national value set of the EQ-5D-5L questionnaire for Iran.

methodsThe composite time trade-off (cTTO) and discrete choice experiment (DCE) methods; and the protocol for EuroQol Portable Valuation Technology (EQ-PVT) were used to estimate the Iran national value set. 1179 face-to-face computer-assisted interviews were conducted with adults that were recruited from five Iran major cities in 2021. Generalized least squares, Tobit, heteroskedastic, logit, and hybrid models were used to analyze the data and to identify the best fitting model.

resultsAccording to the logical consistency of the parameters, significance levels and prediction accuracy indices of the MAE; a heteroscedastic censored Tobit hybrid model combining cTTO and DCE responses was considered as the best fitting model to estimate the final value set. The predicted values ranged from - 1.19 for the worst health state (55555) to 1 for full health (11111), with 53.6% of the predicted values being negative. Mobility was the most influential dimension on health state preference values.

conclusionsThe present study estimated a national EQ-5D-5L value set for Iranian policy makers and researchers. The value set enables the EQ-5D-5L questionnaire to use to calculate QALYs to assist the priority setting and efficient allocation of limited healthcare resources.

Indexed as

Health StatusQuality of LifeAdultChoice BehaviorHumansIranSurveys and QuestionnairesComposite time trade-offDiscrete choice experimentEQ-5D-5LHealth state valuationIran

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.